Microbiota as a new pathogenetic factor in the development of chronic hyperuricemia and gout. Part 2: gout therapy and the gut microbiota
The article presents current data on the effect of drugs for the treatment of gout on the composition and function of the intestinal microbiota. The potential possibilities of pre- and probiotics use for the prevention and complex therapy of gout are discussed, therapeutic effect may be associated w...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2022-12-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/1366 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1839574079905988608 |
|---|---|
| author | M. S. Eliseev E. N. Kharlamova O. V. Zhelyabina A. M. Lila |
| author_facet | M. S. Eliseev E. N. Kharlamova O. V. Zhelyabina A. M. Lila |
| author_sort | M. S. Eliseev |
| collection | DOAJ |
| description | The article presents current data on the effect of drugs for the treatment of gout on the composition and function of the intestinal microbiota. The potential possibilities of pre- and probiotics use for the prevention and complex therapy of gout are discussed, therapeutic effect may be associated with their impact on the uric acid synthesis and intestinal excretion, as well as with anti-inflammatory properties. The need for further research in this area is emphasized. |
| format | Article |
| id | doaj-art-2e32cb6a1e1a46e58d8c50f3b0c8d7b0 |
| institution | Matheson Library |
| issn | 1996-7012 2310-158X |
| language | Russian |
| publishDate | 2022-12-01 |
| publisher | IMA-PRESS LLC |
| record_format | Article |
| series | Современная ревматология |
| spelling | doaj-art-2e32cb6a1e1a46e58d8c50f3b0c8d7b02025-08-04T14:00:38ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2022-12-0116671110.14412/1996-7012-2022-6-7-112531Microbiota as a new pathogenetic factor in the development of chronic hyperuricemia and gout. Part 2: gout therapy and the gut microbiotaM. S. Eliseev0E. N. Kharlamova1O. V. Zhelyabina2A. M. Lila3V.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of Rheumatology; Russian Medical Academy of Continuing Professional Education, Ministry of Health of RussiaThe article presents current data on the effect of drugs for the treatment of gout on the composition and function of the intestinal microbiota. The potential possibilities of pre- and probiotics use for the prevention and complex therapy of gout are discussed, therapeutic effect may be associated with their impact on the uric acid synthesis and intestinal excretion, as well as with anti-inflammatory properties. The need for further research in this area is emphasized.https://mrj.ima-press.net/mrj/article/view/1366microbiotagouthyperuricemiaprobioticsprebioticsfebuxostatallopurinol |
| spellingShingle | M. S. Eliseev E. N. Kharlamova O. V. Zhelyabina A. M. Lila Microbiota as a new pathogenetic factor in the development of chronic hyperuricemia and gout. Part 2: gout therapy and the gut microbiota Современная ревматология microbiota gout hyperuricemia probiotics prebiotics febuxostat allopurinol |
| title | Microbiota as a new pathogenetic factor in the development of chronic hyperuricemia and gout. Part 2: gout therapy and the gut microbiota |
| title_full | Microbiota as a new pathogenetic factor in the development of chronic hyperuricemia and gout. Part 2: gout therapy and the gut microbiota |
| title_fullStr | Microbiota as a new pathogenetic factor in the development of chronic hyperuricemia and gout. Part 2: gout therapy and the gut microbiota |
| title_full_unstemmed | Microbiota as a new pathogenetic factor in the development of chronic hyperuricemia and gout. Part 2: gout therapy and the gut microbiota |
| title_short | Microbiota as a new pathogenetic factor in the development of chronic hyperuricemia and gout. Part 2: gout therapy and the gut microbiota |
| title_sort | microbiota as a new pathogenetic factor in the development of chronic hyperuricemia and gout part 2 gout therapy and the gut microbiota |
| topic | microbiota gout hyperuricemia probiotics prebiotics febuxostat allopurinol |
| url | https://mrj.ima-press.net/mrj/article/view/1366 |
| work_keys_str_mv | AT mseliseev microbiotaasanewpathogeneticfactorinthedevelopmentofchronichyperuricemiaandgoutpart2gouttherapyandthegutmicrobiota AT enkharlamova microbiotaasanewpathogeneticfactorinthedevelopmentofchronichyperuricemiaandgoutpart2gouttherapyandthegutmicrobiota AT ovzhelyabina microbiotaasanewpathogeneticfactorinthedevelopmentofchronichyperuricemiaandgoutpart2gouttherapyandthegutmicrobiota AT amlila microbiotaasanewpathogeneticfactorinthedevelopmentofchronichyperuricemiaandgoutpart2gouttherapyandthegutmicrobiota |